Bright Minds Biosciences IncCanadian Securities Exchange:DRUGView on NASDAQ
- LAST PRICE45.1800
- TODAY'S CHANGE (%)-1.8100 (-3.8519%)
- Bid / Lots15.5000/ 2
- Ask / Lots59.5900/ 2
- Open / Previous Close45.7300 / 46.9900
- Day Range
- 52 Week Range
- Volume8,915
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DRUG |
|---|---|---|
| 09:32 ET | 100 | 45.73 |
| 09:35 ET | 600 | 45.85 |
| 09:39 ET | 300 | 45.64 |
| 09:42 ET | 200 | 45.09 |
| 09:51 ET | 200 | 43.89 |
| 09:55 ET | 100 | 44.19 |
| 10:00 ET | 300 | 43.25 |
| 10:04 ET | 100 | 42.71 |
| 10:08 ET | 200 | 43.88 |
| 10:11 ET | 100 | 43.64 |
| 10:15 ET | 100 | 43.5 |
| 10:20 ET | 100 | 43.51 |
| 10:24 ET | 100 | 43.7 |
| 10:27 ET | 100 | 43.45 |
| 10:31 ET | 100 | 43.45 |
| 10:33 ET | 300 | 42.75 |
| 10:51 ET | 100 | 43.09 |
| 11:12 ET | 100 | 44.2 |
| 11:20 ET | 100 | 43.96 |
| 11:23 ET | 100 | 44.79 |
| 11:34 ET | 500 | 45.61 |
| 12:12 ET | 100 | 44.56 |
| 12:15 ET | 100 | 44.6 |
| 12:21 ET | 100 | 44.54 |
| 12:24 ET | 100 | 44.54 |
| 12:28 ET | 100 | 44.54 |
| 12:30 ET | 100 | 44.95 |
| 12:44 ET | 100 | 45.28 |
| 12:55 ET | 100 | 44.84 |
| 01:06 ET | 100 | 44.88 |
| 01:13 ET | 100 | 45.28 |
| 01:18 ET | 100 | 44.92 |
| 01:24 ET | 400 | 45.28 |
| 01:26 ET | 100 | 45.28 |
| 02:05 ET | 100 | 44.61 |
| 02:09 ET | 100 | 44.6 |
| 02:21 ET | 100 | 44.67 |
| 02:30 ET | 100 | 44.8 |
| 02:34 ET | 100 | 44.6 |
| 03:10 ET | 200 | 44.46 |
| 03:14 ET | 100 | 44.81 |
| 03:17 ET | 200 | 44.93 |
| 03:21 ET | 100 | 44.52 |
| 03:24 ET | 500 | 44.5 |
| 03:26 ET | 200 | 44.7 |
| 03:30 ET | 100 | 44.66 |
| 03:33 ET | 100 | 44.72 |
| 03:37 ET | 100 | 44.65 |
| 03:42 ET | 200 | 44.81 |
| 03:46 ET | 100 | 45.08 |
| 03:57 ET | 200 | 44.98 |
| 04:00 ET | 600 | 45.18 |
Yesterday
Nov 4, 2024
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement, from 2:41PM ET on Monday Nov 04, 2024 by Dow Jones
2:41PM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bright Minds Biosciences Inc | 326.5M | -49.0x | --- |
Cybin Inc | 311.3M | -1.6x | --- |
Eupraxia Pharmaceuticals Inc | 179.2M | -3.4x | --- |
Zentek Ltd | 178.0M | -15.1x | --- |
Cardiol Therapeutics Inc | 174.2M | -4.2x | --- |
NervGen Pharma Corp | 157.5M | -6.8x | --- |
Company Information
Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.
Contact Information
- Headquarters
- 19 Vestry StreetNEW YORK, NY, United States 10013
- Phone
- 647-865-8622
- Fax
- ---
Executives
- President, Chief Executive Officer, Director
- Ian Mcdonald
- Chief Financial Officer
- Ryan Cheung
- Chief Scientific Officer, Director
- Jan Pedersen
- Chief Medical Officer
- Mark Smith
- Independent Director
- Nils Bottler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $313.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.9M |
Bright Minds Biosciences Inc does not pay a dividend. | |
Beta | 0.47 |
EPS | $-0.92 |
Book Value | $1.75 |
P/E Ratio | -49.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
